Click to print
Scientific Programme
Thursday, November 1, 2018
| 13:30-18:30 | Fertility preservation hands-on workshop Workshop Director: Dror Meirow Preregistration needed (limited seats are available) |
15:30-18:30 | Free Industry Sponsored Course |
| 18:30 | Welcome reception | ||
Friday, November 2, 2018
| 08:30-10:05 | Session 1: On the forefront of human oocyte biology: aging, bioenergetics, and epigenetics Chairs: Milton Leong, Hong Kong and Zeev Shoham, Israel |
|---|---|
| 08:30-09:00 | Much more than the spindle: a new perspective on cytoplasmic maturation Gerald Schatten, USA |
| 09:00-09:30 | Comparative biology of oocyte aging Pierre Comizzoli, USA |
| 09:30-10:00 | Human immature oocytes can be grown to maturity in vitro: next steps towards clinical application Evelyn Telfer, UK |
| 10:00-10:05 | Q&A |
| 10:05-10:30 | Coffee break |
| 10:30-13:00 | Session 2: Gamete reconstruction Chairs: Micheline Misrahi, France and Johan Smitz, Belgium |
| 10:30-11:00 | Testing the potential of in vitro grown oocytes Helen Picton, UK |
| 11:00-11:30 | Drug-free IVA as an infertility treatment for aging poor responders Kazuhiro Kawamura, Japan |
| 11:30-12:00 | Direct gamete differentiation from somatic cells? Pasqualino Loi, Italy |
| 12:00-12:30 | Autologous stem cell ovarian transplantation Sonia Herraiz, Spain |
| 12:30-13:00 | Unraveling the human ovary to make new eggs: A tale of two cell types Evelyn Telfer, UK |
| 13:00-14:00 | Lunch Break |
| 14:00-16:00 | Session 3: Embryo development Chair: Norbert Gleicher, USA |
| 14:00-14:30 | Impact of assisted reproduction on genomic imprinting Mellissa Mann, USA |
| 14:30-15:00 | Advances in understanding the mechanisms regulating human oocyte activation and growth Helen Picton, UK |
| 15:00-15:30 | Primordial follicle recruitment and saving ovarian reserve Sherman Silber, USA |
| 15:30-16:00 | A noninvasive approach for human oocyte and embryo selection in IVF derived from new insights into the relationship between developmental competence and bioenergetics Jonathan Van Blerkom, USA |
| 16:00-16:30 | Coffee break |
| 16:30-18:00 | Session 4: Are we ready for genome editing in human embryos FOR CLINICAL PURPOSES? Moderator: Alan Handyside, UK |
| 16:30-17:15 | For Gerald Schatten, USA |
| 17:15-18:00 | Against Joyce Harper, UK |
Saturday, November 3, 2018
| 08:30-10:30 | Session 5: Implantation, luteal support and tissue cryopreservation Chairs: Jacques Donnez, Belgium and Matan Yemini, USA |
|---|---|
| 08:30-09:00 | How do we choose the best progesterone to support the luteal phase? Herman Tournaye, Belgium |
| 09:00-09:30 | The role of polar body genetic testing for aneuploidy in ART treatment Robert Fischer, Germany |
| 09:30-10:00 | Freeze-dry: are we reaching the clinical stage? Amir Arav, Israel |
| 10:00-10:30 | Four simple minimum rules to follow for generating a mammalian blastocyst Joshua Brickman, Denmark |
| 10:30 -11:00 | Coffee break |
| 11:00-13:00 | Session 6: Stimulation, oocyte maturation and ovarian tissue freezing Chairs: Robert Fischer, Germany and Ariel Weissman, Israel |
| 11:00-11:30 | A more physiological approach to stimulation Milton Leong, Hong Kong |
| 11:30-12:00 | First clinical results of capacitation culture preceding in vitro maturation of human oocytes from small antral follicles in PCOS Johan Smitz, Belgium |
| 12:00-12:30 | Single center success in freezing ovarian tissue: How we overcome the various obstacles Dror Meirow, Israel |
| 12:30-13:00 | A critical review of ovarian tissue freezing Jacques Donnez, Belgium |
| 13:00-14:00 | Lunch Break |
| 14:00-16:00 | Session 7: 40 years of IVF: Best practices with respect to outcome, based on accumulated outcome results Chairs: Samir Hamamah, France and Sherman Silber, USA |
| 14:00-14:30 | Managing young women approaching menopause, with high FSH and low AMH Norbert Gleicher, USA |
| 14:30-15:00 | Ovarian stimulation for freeze-all: is it just the same? Ariel Weissman, Israel |
| 15:00-15:30 | What causes genomic instability in preimplantation human embryos? David Keefe, USA |
| 15:30-16:00 | It is now confirmed: No additional risk of ovarian, breast, and corpus uteri cancer in women treated with ART in Great Britain, data including 2.2 million-person years of observation Alastair Sutcliff, UK |
| 16:00-16:30 | Coffee break |
| 16:30-18:30 | Session 8: The embryo Chairs: Milton Leong, Hong Kong and Zeev Shoham, Israel |
| 16:30-17:00 | Hormonal regulation of embryo transport Kenneth Korach, USA |
| 17:00-17:30 | Nuclear transfer: Clinical applications Valery Zukin, Ukraine |
| 17:30-18:00 | New challenges of mitochondria research in ART Chii Ruey Tzeng, Taiwan |
| 18:00-18:30 | MicroRNAs beyond gene expression to detect implantation window Samir Hamamah, France |